121 related articles for article (PubMed ID: 35005862)
21. An evaluation of the benefits of a topical treatment in the improvement of photodamaged hands with age spots, freckles, and/or discolorations.
Gold MH; Gallagher C
J Drugs Dermatol; 2013 Dec; 12(12):1468-72. PubMed ID: 24301250
[TBL] [Abstract][Full Text] [Related]
22. Facial tolerability of topical retinoid therapy.
Leyden J; Grove G; Zerweck C
J Drugs Dermatol; 2004; 3(6):641-51. PubMed ID: 15624747
[TBL] [Abstract][Full Text] [Related]
23. A Double-Blind, 12-Week Study to Evaluate the Antiaging Efficacy of a Cream Containing the NFκB Inhibitor 4-Hexyl-1, 3-Phenylenediol and Ascorbic Acid-2 Glucoside in Adult Females.
Roure R; Nollent V; Dayan L; Camel E; Bertin C
J Drugs Dermatol; 2016 Jun; 15(6):750-8. PubMed ID: 27272084
[TBL] [Abstract][Full Text] [Related]
24. Cosmetic benefits of a novel biomimetic lamellar formulation containing niacinamide in healthy females with oily, blemish-prone skin in a randomized proof-of-concept study.
Santos-Caetano JP; Gfeller CF; Mahalingam H; Thompson M; Moore DJ; Vila R; Doi R; Cargill MR
Int J Cosmet Sci; 2020 Feb; 42(1):29-35. PubMed ID: 31461548
[TBL] [Abstract][Full Text] [Related]
25. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
Serra M; Bohnert K; Narda M; Granger C; Sadick N
J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
[TBL] [Abstract][Full Text] [Related]
26. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
[TBL] [Abstract][Full Text] [Related]
27. An International Evaluation of a Ceramide-Containing Hydrating Cleanser and Moisturizing Cream for the Improvement of Diabetes Mellitus-Related Xerosis.
Kirsner R; Andriessen A
J Drugs Dermatol; 2023 Jan; 22(1):65-73. PubMed ID: 36607758
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
Gold M; Dhawan S; Verma A; Kuligowski M; Dobrowski D
J Drugs Dermatol; 2016 Jun; 15(6):743-8. PubMed ID: 27272083
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Tolerability of a Skin Brightening/Anti-Aging Cosmeceutical Containing Retinol 0.5%, Niacinamide, Hexylresorcinol, and Resveratrol.
Farris P; Zeichner J; Berson D
J Drugs Dermatol; 2016 Jul; 15(7):863-8. PubMed ID: 27391637
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.
Gold LS; Papp K; Lynde C; Lain E; Gooderham M; Johnson S; Kerrouche N
J Drugs Dermatol; 2017 Sep; 16(9):909-916. PubMed ID: 28915286
[TBL] [Abstract][Full Text] [Related]
31. Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis.
Tanghetti EA; Werschler WP; Lain E; Guenin E; Harris S; Loncaric A; Pillai R
J Drugs Dermatol; 2020 Mar; 19(3):272-279. PubMed ID: 32549090
[TBL] [Abstract][Full Text] [Related]
32. Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
Zirwas MJ; Barkovic S
J Drugs Dermatol; 2017 Mar; 16(3):243-247. PubMed ID: 28301620
[TBL] [Abstract][Full Text] [Related]
33. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris.
Tanghetti EA; Kircik LH; Green LJ; Guenin E; Harris S; Martin G; Pillai R
J Drugs Dermatol; 2019 Jun; 18(6):542. PubMed ID: 31251546
[TBL] [Abstract][Full Text] [Related]
34. Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.
Blume-Peytavi U; Fowler J; Kemény L; Draelos Z; Cook-Bolden F; Dirschka T; Eichenfield L; Graeber M; Ahmad F; Alió Saenz A; Rich P; Tanghetti E
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):166-173. PubMed ID: 31306527
[TBL] [Abstract][Full Text] [Related]
35. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
[TBL] [Abstract][Full Text] [Related]
36. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
Lain E; Day D; Harper J; Guenin E
J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
[TBL] [Abstract][Full Text] [Related]
37. Topical tretinoin improves the appearance of photo damaged skin.
Lowe PM; Woods J; Lewis A; Davies A; Cooper AJ
Australas J Dermatol; 1994; 35(1):1-9. PubMed ID: 7998893
[TBL] [Abstract][Full Text] [Related]
38. A Multi-center Trial Evaluating a Serum Comprised of Plant-based Adaptogens Targeting Skin Quality.
Draelos ZD; Grimes PE; Watchmaker J; Nelson DB
J Clin Aesthet Dermatol; 2024 Feb; 17(2):15-19. PubMed ID: 38444422
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
[TBL] [Abstract][Full Text] [Related]
40. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
